Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.
NCT02028637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59
Last updated 2014-01-07
Summary
Introduction: Recently it has involved the role of TLR (toll-like receptors) in the pathogenesis of asthma. TLRs are a family of proteins responsible for the recognition of Pathogen-Associated Molecular Patters (PAMPs). The possible role that TLRs play in IgE-dependent asthma (not eosinophilic) and its recognition as a new endotype asthma, could open new therapeutic expectations.
Objective: To analyze the expression of TLR 2 and 4 in monocytes/ macrophages and neutrophils in peripheral blood and induced sputum from asthmatic patients
Conditions
Interventions
- OTHER
-
TLRs
Recently it has involved the role of TLR (toll-like receptors) in the pathogenesis of asthma.The possible role that TLRs play in the asthma and its recognition as a new endotype asthma, could open new therapeutic expectations.
Sponsors & Collaborators
-
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
lead OTHER
Principal Investigators
-
Astrid Crespo · Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau. Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau). Universitat Autònoma de Barcelona, Department of Medicine.
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- Spain
Study Locations
More Related Trials
-
Detection of Cav1 Calcium Channels in Inflammatory Cells of Asthmatic Children
NCT02809560 ·Status: COMPLETED ·Phase: NA
-
Innate Immunity in Allergic Asthma
NCT06068335 ·Status: RECRUITING
-
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
NCT01711593 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of Tralokinumab in Adults With Asthma
NCT01402986 ·Status: COMPLETED ·Phase: PHASE2
-
Total IgE (Immunoglobulin E) and Der p 1 (d1) Specific IgE in Induced Sputum in Patients With Allergic and Non-allergic Asthma
NCT03640936 ·Status: COMPLETED
-
An Investigation of Tumor Necrosis Factor (TNF)-Alpha in Asthma Using Biopsy Explants and Primary Bronchial Epithelial Cell Cultures
NCT01161303 ·Status: COMPLETED
-
Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma
NCT00550797 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)
NCT00401596 ·Status: COMPLETED ·Phase: PHASE3
-
mRNA Expression as a Biomarker of Omalizumab Response
NCT01584687 ·Status: UNKNOWN ·Phase: PHASE4
-
Molecular Mechanism of Asthma
NCT00180726 ·Status: WITHDRAWN ·Phase: NA
-
Microbiome and Exacerbations in Neutrophilic Asthma
NCT04260282 ·Status: UNKNOWN
-
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 ·Status: RECRUITING ·Phase: NA
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins
NCT05762627 ·Status: NOT_YET_RECRUITING
-
TC-6987 for the Treatment of Mild to Moderate Asthma
NCT01296087 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
NCT01007149 ·Status: COMPLETED ·Phase: PHASE3
-
Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)
NCT01414868 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
NCT01370317 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
NCT01589198 ·Status: COMPLETED
-
Clinical Relevance of Small Airways Disease in Severe Asthma Patients Treated With Anti-InterLeukin-5 Therapy
NCT05706597 ·Status: UNKNOWN
-
Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma
NCT03784781 ·Status: WITHDRAWN
-
Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT
NCT00021931 ·Status: COMPLETED
-
The Effects of Montelukast on Smokers With Asthma
NCT00712335 ·Status: COMPLETED ·Phase: PHASE4
-
B2-Adrenergic Receptor Polymorphisms
NCT00279786 ·Status: COMPLETED